Patent 7256279 was granted and assigned to Takeda Pharmaceutical Company on August, 2007 by the United States Patent and Trademark Office.
A protein having ribonucleotide reductase activity, DNA encoding the protein, antibodies to these and the like are disclosed. The protein, DNA and antibodies are useful in the prevention, treatment and diagnosis, etc. of cancer.